[Preliminary note on the clinical trial of a combination of histamine, human gamma globulin and serotonin for the radical desensitizing therapy of allergic diseases, with special reference to bronchial asthma, headaches and allergic dermatoses. I].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001249:Asthma / Q000188:drug therapy*; D002648:Child; D003877:Dermatitis, Contact / Q000188:drug therapy*; D003888:Desensitization, Immunologic; D005260:Female; D006261:Headache / Q000188:drug therapy*; D006632:Histamine / Q000627:therapeutic use*; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy*; D012701:Serotonin / Q000627:therapeutic use*; D014653:Vascular Headaches / Q000188:drug therapy; D005719:gamma-Globulins / Q000627:therapeutic use*
D005719:gamma-Globulins; D012701:Serotonin; D006632:Histamine
Nota preliminare sulla sperimentazione clinica di un composto istamina-gammaglobuline umane-serotonina per il trattamento desensibilizzante radicale delle allergopatie con particolare riguardo all'asma bronchiale, alle cefalee ed alle dermatosi allergiche. I.